TREVI THERAPEUTICS INC (TRVI) Stock Balance Sheet
NASDAQ:TRVI - Nasdaq - US89532M1018 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 19.37M | 34.10M | 32.40M | 12.60M | 36.80M | |||
| Marketable Securities | 83.88M | 73.53M | 50.57M | 107.90M | N/A | |||
| Receivables | 830.00K | 870.00K | 960.00K | 1.30M | 200.00K | |||
| Other Current Assets | 1.53M | 940.00K | 3.62M | 800.00K | 900.00K | |||
| Total Current Assets | 106.00M | 109.00M | 88.00M | 122.60M | 38.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.14M | 1.23M | 1.56M | 200.00K | 200.00K | |||
| Other Non-Current Assets | 240.00K | 240.00K | 300.00K | 200.00K | 300.00K | |||
| Total Non-Current Assets | 1.00M | 2.00M | 1.00M | 400.00K | 500.00K | |||
| TOTAL ASSETS | 107.00M | 111.00M | 89.00M | 123.00M | 38.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 0.00 | 30.00K | 120.00K | 7.00M | 5.90M | |||
| Accrued Expenses | 5.45M | 7.06M | 3.89M | 3.00M | 3.80M | |||
| Accounts Payable | 1.42M | 3.41M | 1.81M | 2.90M | 2.80M | |||
| Other Current Liabilities | N/A | N/A | N/A | 500.00K | 100.00K | |||
| Total Current Liabilities | 6.87M | 11.00M | 5.82M | 13.40M | 12.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 30.00K | 2.20M | 8.70M | |||
| Other Non-Current Liabilities | 680.00K | 750.00K | 1.00M | 0.00 | 0.00 | |||
| Total Non-Current Liabilities | 680.00K | 0.00 | 1.04M | 2.20M | 8.70M | |||
| TOTAL LIABILITIES | 7.55M | 11.00M | 6.86M | 15.60M | 21.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -297.00M | -287.00M | -239.00M | -210.10M | -180.90M | |||
| Additional Paid In Capital | 397.00M | 387.00M | 322.00M | 317.60M | 198.00M | |||
| Common Shares | 100.00K | 90.00K | 70.00K | 100.00K | 0.00 | |||
| Other Shareholders' Equity | 70.00K | 60.00K | -30.00K | -100.00K | N/A | |||
| Shares Outstanding | 100.00M | 94.00M | 68.00M | 59.90M | 28.50M | |||
| Tangible Book Value per Share | 1.00 | 1.06 | 1.21 | 1.79 | 0.60 | |||
| Total Shareholders' Equity | 99.00M | 100.00M | 83.00M | 107.50M | 17.10M | |||
| TOTAL LIABILITIES AND EQUITY | 107.00M | 111.00M | 89.00M | 123.00M | 38.50M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | 0.00 | 0.02 | 0.51 | |||
| Current Ratio | 15.43 | 9.91 | 15.12 | 9.15 | 2.99 | |||
| Return On Assets (ROA) | -42.99% | -43.24% | -32.58% | -23.70% | -88.16% | |||
| Return On Equity (ROE) | -46.46% | -48.00% | -34.94% | -27.12% | -198.48% | |||
All data in USD , ROIC based on taxRate of 0.21